FdaApplication
NDA 021344
Identifiers
- fda_app_no: NDA021344
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA PHARMACEUTICALS LP |
| application_type | NDA |
| approval_date | 2002-04-25 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FASLODEX | FULVESTRANT | 125MG/2.5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR |
| FASLODEX | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR |
2 products